Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 190.43

-0.7%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J Stone who wrote (28232)	2/18/1999 11:27:00 AM
From: Machaon	Read Replies (1) of 32384

While this has been a disappointing setback in the LGND stock price, and in Ligands milestone payments, the news could've been a lot worse. Lilly could've dropped the program with Ligand completely. Instead, they want to continue forward, switching to Ligand's 2nd generation products. It makes sense to me for them to move to the second generation products, with better therapeutic indexes, even though it sets back the schedule. There was an interesting comment from Robinson: " ... the return of Targretin rights will now permit us to rapidly generate revenues from distribution agreements pending in territories in which we will not directly market Targretin in oncology and dermatology,' said Ligand Chairman, President and CEO David E. Robinson." Can anyone give a translation for what this means?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next